BBY
49
9
MTCH
50
4
HD
37
2
AA
51
-9
AN
50
-15
HON
62
4
CMI
47
2
AIV
62
11
PBI
60
-2
PSX
42
-2
FDX
47
4
ORCL
59
-3
SNA
48
2
EXPD
37
3
IBM
62
-2
AMZN
63
4
VIX
19
-3
CA
12
-3
PRU
59
-3
UNH
28
5
BBY
49
9
MTCH
50
4
HD
37
2
AA
51
-9
AN
50
-15
HON
62
4
CMI
47
2
AIV
62
11
PBI
60
-2
PSX
42
-2
FDX
47
4
ORCL
59
-3
SNA
48
2
EXPD
37
3
IBM
62
-2
AMZN
63
4
VIX
19
-3
CA
12
-3
PRU
59
-3
UNH
28
5
Financhill
Back

NewLake Capital Partners Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
30

NLCP
NewLake Capital Partners

Last Price:
$14.62
Seasonality Move:
-4.81%
Sell
22

APLS
Apellis Pharmaceuticals

Last Price:
$17.44
Seasonality Move:
-14.59%
Sell
30
NewLake Capital Partners (NLCP) is a Sell

Is NewLake Capital Partners a Buy, Sell or Hold?

  • The current NewLake Capital Partners [NLCP] share price is $14.62. The Score for NLCP is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • NLCP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
22
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $17.43. The Score for APLS is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NLCP Stock Price Chart

What is NewLake Capital Partners's stock price today?

  • The NewLake Capital Partners share price today is $14.62
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NLCP is experiencing selling pressure, which indicates risk of future bearish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $17.43
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing selling pressure, which indicates risk of future bearish movement.

NLCP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.05 Buy
Relative Strength Index (14 RSI): 49.32 Sell
Chaikin Money Flow: -51415 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (14.35 - 14.81) Buy
Bollinger Bands (100): (14.03 - 15.75) Sell

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.13 Sell
Relative Strength Index (14 RSI): 41.91 Sell
Chaikin Money Flow: -3543940 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.42 - 19.1) Sell
Bollinger Bands (100): (17.42 - 25.66) Sell

NLCP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 14.7 Sell
20-day SMA: 14.67 Sell
50-day SMA: 14.54 Buy
200-day SMA: 16.81 Sell
8-day EMA: 14.69 Sell
20-day EMA: 14.66 Sell
50-day EMA: 14.67 Sell
200-day EMA: 16.06 Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 17.96 Sell
20-day SMA: 18.5 Sell
50-day SMA: 18.15 Sell
200-day SMA: 26.32 Sell
8-day EMA: 18.1 Sell
20-day EMA: 18.25 Sell
50-day EMA: 19.02 Sell
200-day EMA: 26.54 Sell

NewLake Capital Partners Earnings Growth & NLCP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.05 per share, an increase next quarter of $0.05 per share, a decrease this year of $0.13 per share, and an increase next year of $0.07 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.19 per share, a decrease this year of $0.13 per share, and an increase next year of $1.13 per share.

NewLake Capital Partners Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):